Mary Jo LaDu
- Physiology top 0.1%
- Alzheimer's disease research and treatments 78
- Neurology top 0.2%
- Neuroinflammation and Neurodegeneration Mechanisms 20
- Biological Psychiatry top 0.5%
- Cellular and Molecular Neuroscience top 0.5%
- Nuclear Receptors and Signaling 20
- Neuroscience and Neuropharmacology Research 9
- Pharmacology top 0.5%
- Cholinesterase and Neurodegenerative Diseases 16
-
- Computational Drug Discovery Methods 19
-
- Cholesterol and Lipid Metabolism 13
-
- Drug Transport and Resistance Mechanisms 7
- Co-authors
- W. Blaine StineGrant A. KrafftArlene M. ManelliGodfrey S. GetzCatherine A. ReardonChunjiang YuLorinda K. BakerLeon M. Tai
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (11 papers)Journal of Neuroscience (3 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Mary Jo LaDu
105 papers receiving 9.5k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Physiology 7.1k
- Neurology 1.9k
- Biological Psychiatry 454
- Cellular and Molecular Neuroscience 2.0k
- Pharmacology 1.3k
Countries citing papers authored by Mary Jo LaDu
This map shows the geographic impact of Mary Jo LaDu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Jo LaDu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Jo LaDu more than expected).
Fields of papers citing papers by Mary Jo LaDu
This network shows the impact of papers produced by Mary Jo LaDu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Jo LaDu. The network helps show where Mary Jo LaDu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mary Jo LaDu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 7 | |
| 4 | 2022 | 30 | |
| 5 | 2021 | 12 | |
| 6 | 2020 | 43 | |
| 7 | 2019 | 69 | |
| 8 | 2017 | 14 | |
| 9 | 2016 | 30 | |
| 10 | 2016 | 30 | |
| 11 | 2016 | 17 | |
| 12 | 2013 | 128 | |
| 13 | 2012 | 214 | |
| 14 | 2012 | 143 | |
| 15 | 2012 | 143 | |
| 16 | 2010 | 173 | |
| 17 | 2009 | 170 | |
| 18 | 2005 | 22 | |
| 19 | 2004 | 69 | |
| 20 | 1991 | 5 |
About Mary Jo LaDu
Mary Jo LaDu is a scholar working on Physiology, Neurology and Cellular and Molecular Neuroscience, having authored 105 papers that have together received 9.6k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (78 papers), Neuroinflammation and Neurodegeneration Mechanisms (20 papers), Nuclear Receptors and Signaling (20 papers), Computational Drug Discovery Methods (19 papers), Cholinesterase and Neurodegenerative Diseases (16 papers), Cholesterol and Lipid Metabolism (13 papers), Neuroscience and Neuropharmacology Research (9 papers) and Drug Transport and Resistance Mechanisms (7 papers). The work is most often cited by research in Physiology (7.1k citations), Neurology (1.9k citations) and Biological Psychiatry (454 citations). Mary Jo LaDu has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include W. Blaine Stine, Grant A. Krafft, Arlene M. Manelli, Godfrey S. Getz, Catherine A. Reardon, Chunjiang Yu, Lorinda K. Baker, Leon M. Tai, Linda J. Van Eldik and Guojun Bu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.